146 related articles for article (PubMed ID: 11794405)
1. Small hepatocellular carcinoma: therapeutic effectiveness of percutaneous radio frequency ablation therapy with a LeVeen needle electrode.
Shirato K; Morimoto M; Tomita N; Kokawa A; Sugimori K; Saito T; Numata K; Sekihara H; Tanaka K
J Ultrasound Med; 2002 Jan; 21(1):67-76. PubMed ID: 11794405
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma.
Solmi L; Nigro G; Roda E
World J Gastroenterol; 2006 Feb; 12(7):1098-104. PubMed ID: 16534852
[TBL] [Abstract][Full Text] [Related]
3. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent.
Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Kim H; Lee SJ; Lim JH
J Ultrasound Med; 2002 Apr; 21(4):391-401. PubMed ID: 11934096
[TBL] [Abstract][Full Text] [Related]
4. Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation.
Morimoto M; Nozawa A; Numata K; Shirato K; Sugimori K; Kokawa A; Tomita N; Saitou T; Nakatani Y; Imada T; Tanaka K
J Ultrasound Med; 2005 Mar; 24(3):273-83. PubMed ID: 15723840
[TBL] [Abstract][Full Text] [Related]
5. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent.
Choi D; Lim HK; Lee WJ; Kim SH; Kim YH; Kim SH; Lim JH
J Ultrasound Med; 2003 Nov; 22(11):1163-72. PubMed ID: 14620886
[TBL] [Abstract][Full Text] [Related]
6. [Echo-guided radiofrequency percutaneous ablation of hepatocellular carcinoma in cirrhosis using a cooled needle].
Marone G; Francica G; D'Angelo V; Iodice G; Pastore P; Altamura G; Cusati B; Siani A
Radiol Med; 1998 Jun; 95(6):624-9. PubMed ID: 9717546
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous radio-frequency ablation therapy using a clustered electrode for malignant liver tumors.
Horigome H; Nomura T; Nakao H; Fujino N; Murasaki G; Kanematsu T; Joh T; Ohara H; Itoh M
J Clin Gastroenterol; 2001; 32(5):418-22. PubMed ID: 11319314
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode.
Rossi S; Buscarini E; Garbagnati F; Di Stasi M; Quaretti P; Rago M; Zangrandi A; Andreola S; Silverman D; Buscarini L
AJR Am J Roentgenol; 1998 Apr; 170(4):1015-22. PubMed ID: 9530052
[TBL] [Abstract][Full Text] [Related]
9. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous ethanol injection of unresectable medium-to-large-sized hepatomas using a multipronged needle: efficacy and safety.
Ho CS; Kachura JR; Gallinger S; Grant D; Greig P; McGilvray I; Knox J; Sherman M; Wong F; Wong D
Cardiovasc Intervent Radiol; 2007; 30(2):241-7. PubMed ID: 17200905
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma: therapeutic experience with percutaneous ethanol injection under real-time contrast-enhanced color Doppler sonography with the contrast agent Levovist.
Shirato K; Morimoto M; Tomita N; Kokawa A; Sugimori K; Saito T; Numata K; Sekihara H; Tanaka K
J Ultrasound Med; 2002 Sep; 21(9):1015-22. PubMed ID: 12216749
[TBL] [Abstract][Full Text] [Related]
13. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection.
Livraghi T; Goldberg SN; Lazzaroni S; Meloni F; Solbiati L; Gazelle GS
Radiology; 1999 Mar; 210(3):655-61. PubMed ID: 10207464
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategy to optimize radiofrequency ablation for liver malignancies.
Chen MH; Wei Y; Yan K; Gao W; Dai Y; Huo L; Yin SS; Zhang H; Poon RT
J Vasc Interv Radiol; 2006 Apr; 17(4):671-83. PubMed ID: 16614151
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma.
Giorgio A; Tarantino L; de Stefano G; Scala V; Liorre G; Scarano F; Perrotta A; Farella N; Aloisio V; Mariniello N; Coppola C; Francica G; Ferraioli G
AJR Am J Roentgenol; 2003 Aug; 181(2):479-84. PubMed ID: 12876030
[TBL] [Abstract][Full Text] [Related]
16. [The echo-guided interstitial laser photocoagulation of malignant liver tumors. The authors' personal technic, immediate results and short-term complications in patients with normal and altered liver function].
Giorgio A; Tarantino L; De Stefano G; Farella N; Catalano O; Cusati B; Del Viscovo L; Alaia A
Radiol Med; 2000 Apr; 99(4):264-9. PubMed ID: 10884827
[TBL] [Abstract][Full Text] [Related]
17. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness.
Sartori S; Tombesi P; Macario F; Nielsen I; Tassinari D; Catellani M; Abbasciano V
Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance.
Kim JE; Kim YS; Rhim H; Lim HK; Lee MW; Choi D; Shin SW; Cho SK
Eur J Radiol; 2011 Aug; 79(2):e80-4. PubMed ID: 21514757
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous sonographically guided radio frequency ablation of hepatocellular carcinoma: causes of mistargeting and factors affecting the feasibility of a second ablation session.
Lee MW; Lim HK; Kim YJ; Choi D; Kim YS; Lee WJ; Cha DI; Park MJ; Rhim H
J Ultrasound Med; 2011 May; 30(5):607-15. PubMed ID: 21527608
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
